Asia's Top 10 Cell Culture Rabies Vaccines Brand List

June 05, 2024

Cell culture rabies vaccines are becoming increasingly popular due to their safety and efficacy compared to traditional vaccines. Advancements in biotechnology are leading to the development of more cost-effective and efficient production methods. There is a growing demand for these vaccines in both human and veterinary medicine, driving innovation and investment in the industry.

Verorab
HDCV
Purified Vero Cell Rabies Vaccine
Rabipur
Changchun Zhuoyi Biological Co., Ltd
PCECV
Vaxirab
Rabivax-S

Verorab

Establishment time : 1978

website : www.sanofipasteur.com

Main Product : Verorab rabies vaccine

Company Profile

Sanofi Pasteur, the manufacturer of Verorab, is a global healthcare company dedicated to preventing and treating infectious diseases. With a history dating back to 1978, Sanofi Pasteur has established itself as a leader in the development and production of vaccines, including the widely used Verorab rabies vaccine. The company's commitment to innovation and quality has made it a trusted partner in public health efforts worldwide.

HDCV

Establishment time : HDCV was established in 2005.

website : www.hdcv.com

Main Product : HDCV's main products include electronic components and devices.

Company Profile

HDCV is a leading provider of high-quality electronic components and devices.

Purified Vero Cell Rabies Vaccine

Establishment time : 1967

website : www.sanofipasteur.com

Main Product : Purified Vero Cell Rabies Vaccine

Company Profile

Sanofi Pasteur, the vaccines division of Sanofi, is a global leader in vaccine development and production. Established in 1967, Sanofi Pasteur is known for its high-quality vaccines, including the Purified Vero Cell Rabies Vaccine. With a large presence in the global market, Sanofi Pasteur continues to innovate and provide essential vaccines to protect public health worldwide.

Rabipur

Establishment time : 1976

website : www.rabipur.com

Main Product : Rabies vaccine

Company Profile

Rabipur is a leading pharmaceutical company that specializes in the production of rabies vaccines. Established in 1976, the company has grown to become a major player in the global market, offering high-quality vaccines to combat rabies worldwide. With a large company size and a strong presence in various markets, Rabipur continues to innovate and provide effective solutions for the prevention of rabies.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

PCECV

Establishment time : PCECV was founded in 1991 with the mission of providing high-quality vaccines for rabies.

website : www.pcecv.com

Main Product : PCECV is a medium-sized company with a global presence, serving markets around the world.

Company Profile

Overall, PCECV is a trusted and reliable partner for those in need of effective rabies vaccines.

Vaxirab

Establishment time : Vaxirab was established in 2018.

website : www.vaxirab.com

Main Product : Rabies vaccine

Company Profile

Vaxirab is a relatively new company specializing in the production of rabies vaccine for global distribution.

Rabivax-S

Establishment time : Rabivax-S is a pharmaceutical company specializing in the production of rabies vaccines.

website :

Main Product : The company's main product, Rabivax-S, is a highly effective vaccine that has been used to prevent rabies in both humans and animals.

Company Profile

As a medium-sized company, Rabivax-S is well-positioned to meet the growing demand for rabies vaccines worldwide.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326